Deep Learning Generates Synthetic Cancer Histology for Explainability and Education
Authors:
James M. Dolezal,
Rachelle Wolk,
Hanna M. Hieromnimon,
Frederick M. Howard,
Andrew Srisuwananukorn,
Dmitry Karpeyev,
Siddhi Ramesh,
Sara Kochanny,
Jung Woo Kwon,
Meghana Agni,
Richard C. Simon,
Chandni Desai,
Raghad Kherallah,
Tung D. Nguyen,
Jefree J. Schulte,
Kimberly Cole,
Galina Khramtsova,
Marina Chiara Garassino,
Aliya N. Husain,
Huihua Li,
Robert Grossman,
Nicole A. Cipriani,
Alexander T. Pearson
Abstract:
Artificial intelligence methods including deep neural networks (DNN) can provide rapid molecular classification of tumors from routine histology with accuracy that matches or exceeds human pathologists. Discerning how neural networks make their predictions remains a significant challenge, but explainability tools help provide insights into what models have learned when corresponding histologic fea…
▽ More
Artificial intelligence methods including deep neural networks (DNN) can provide rapid molecular classification of tumors from routine histology with accuracy that matches or exceeds human pathologists. Discerning how neural networks make their predictions remains a significant challenge, but explainability tools help provide insights into what models have learned when corresponding histologic features are poorly defined. Here, we present a method for improving explainability of DNN models using synthetic histology generated by a conditional generative adversarial network (cGAN). We show that cGANs generate high-quality synthetic histology images that can be leveraged for explaining DNN models trained to classify molecularly-subtyped tumors, exposing histologic features associated with molecular state. Fine-tuning synthetic histology through class and layer blending illustrates nuanced morphologic differences between tumor subtypes. Finally, we demonstrate the use of synthetic histology for augmenting pathologist-in-training education, showing that these intuitive visualizations can reinforce and improve understanding of histologic manifestations of tumor biology.
△ Less
Submitted 9 December, 2022; v1 submitted 11 November, 2022;
originally announced November 2022.
Uncertainty-Informed Deep Learning Models Enable High-Confidence Predictions for Digital Histopathology
Authors:
James M Dolezal,
Andrew Srisuwananukorn,
Dmitry Karpeyev,
Siddhi Ramesh,
Sara Kochanny,
Brittany Cody,
Aaron Mansfield,
Sagar Rakshit,
Radhika Bansa,
Melanie Bois,
Aaron O Bungum,
Jefree J Schulte,
Everett E Vokes,
Marina Chiara Garassino,
Aliya N Husain,
Alexander T Pearson
Abstract:
A model's ability to express its own predictive uncertainty is an essential attribute for maintaining clinical user confidence as computational biomarkers are deployed into real-world medical settings. In the domain of cancer digital histopathology, we describe a novel, clinically-oriented approach to uncertainty quantification (UQ) for whole-slide images, estimating uncertainty using dropout and…
▽ More
A model's ability to express its own predictive uncertainty is an essential attribute for maintaining clinical user confidence as computational biomarkers are deployed into real-world medical settings. In the domain of cancer digital histopathology, we describe a novel, clinically-oriented approach to uncertainty quantification (UQ) for whole-slide images, estimating uncertainty using dropout and calculating thresholds on training data to establish cutoffs for low- and high-confidence predictions. We train models to identify lung adenocarcinoma vs. squamous cell carcinoma and show that high-confidence predictions outperform predictions without UQ, in both cross-validation and testing on two large external datasets spanning multiple institutions. Our testing strategy closely approximates real-world application, with predictions generated on unsupervised, unannotated slides using predetermined thresholds. Furthermore, we show that UQ thresholding remains reliable in the setting of domain shift, with accurate high-confidence predictions of adenocarcinoma vs. squamous cell carcinoma for out-of-distribution, non-lung cancer cohorts.
△ Less
Submitted 9 April, 2022;
originally announced April 2022.
